ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,510Medicare Part D Prescriptions Filled, Including Refills

Rank: 214 out of 761

$878K Total Retail Price of All Prescriptions

Rank: 19 out of 761

383 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 4,966 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 312 212 1 3
SIMVASTATIN 215 192 2 2
LISINOPRIL 194 131 3 1
METOPROLOL SUCCINATE 149 112 4 16
AMLODIPINE BESYLATE 146 108 5 6
ULORIC 134 116 6 250
OMEPRAZOLE 127 92 7 4
GABAPENTIN 126 53 8 15
SYNTHROID 126 105 8 64
WARFARIN SODIUM 117 71 10 9
OXYCODONE HCL 113 24 S2 11 24
METFORMIN HCL 111 74 12 10
HYDROCODONE-ACETAMINOPHEN 107 80 S3 13 5
PRAVASTATIN SODIUM 101 83 14 20
MORPHINE SULFATE ER 97 18 S2 15 38
ATORVASTATIN CALCIUM 92 81 16 12
ACIPHEX 92 51 16 246
CRESTOR 92 50 16 36
TAMSULOSIN HCL 90 71 19 27
DIOVAN 81 65 20 58
TRAMADOL HCL 78 61 21 34
FUROSEMIDE 77 48 22 7
CYMBALTA 75 50 23 53
SERTRALINE HCL 71 49 24 25
WELCHOL 70 57 25 295
DONEPEZIL HCL 70 58 25 33
HYDROMORPHONE HCL 69 27 S2 27 140
OXYCODONE HCL-ACETAMINOPHEN 66 17 S2 28 136
METOPROLOL TARTRATE 66 61 28 14
CITALOPRAM HBR 64 44 30 19
LOSARTAN POTASSIUM 63 42 31 13
TRAZODONE HCL 60 21 32 23
ATENOLOL 60 46 32 8
FENTANYL 54 0 S2 34 57
METHADONE HCL 52 17 S2 35 75
POTASSIUM CHLORIDE 51 34 36 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.